Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Tolerability of Liraglutide in Healthy Male Volunteers

This study has been completed.
Information provided by (Responsible Party):
Novo Nordisk A/S Identifier:
First received: January 5, 2012
Last updated: February 18, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 1999
  Primary Completion Date: December 1999 (Final data collection date for primary outcome measure)